How VEGF-A and its splice variants affect breast cancer development - clinical implications.
Hivin Al KawasInas SaaidPaul JankChristina C WesthoffCarsten DenkertTherese ProssKaroline Barbara Stephanie WeilerMaria Margarete KarstenPublished in: Cellular oncology (Dordrecht) (2022)
b expression is higher in invasive breast cancer tumor cells than in normal tissues or stroma. These examples show that the detection of VEGF splice variants can be performed also on the protein level in formalin fixed tissues. Although no quantitative conclusions can be drawn, these results may be the starting point for further studies at a quantitative level, which can be a major step towards the design of targeted antibody-based (breast) cancer therapies.